| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 655.25M | 574.92M | 551.02M | 387.07M | 307.75M |
| Gross Profit | 375.91M | 244.83M | 267.63M | 301.01M | 281.55M |
| EBITDA | 70.77M | -17.48M | 48.17M | 84.47M | 151.29M |
| Net Income | 52.42M | -15.75M | 32.49M | 63.31M | 112.92M |
Balance Sheet | |||||
| Total Assets | 9.78B | 9.90B | 9.72B | 9.13B | 7.64B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 2.00B | 1.51B | 1.31B | 1.45B |
| Total Debt | 1.04B | 1.00B | 921.33M | 1.20B | 1.07B |
| Total Liabilities | 8.84B | 9.01B | 8.98B | 8.42B | 6.81B |
| Stockholders Equity | 938.80M | 890.47M | 736.07M | 707.82M | 834.48M |
Cash Flow | |||||
| Free Cash Flow | 97.96M | 74.79M | 15.79M | -59.79M | 60.85M |
| Operating Cash Flow | 100.50M | 82.19M | 26.72M | -49.16M | 67.43M |
| Investing Cash Flow | -501.10M | -576.66M | -606.62M | -1.40B | 385.32M |
| Financing Cash Flow | 441.10M | 762.96M | 611.17M | 1.46B | -392.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $1.16B | 11.29 | 13.88% | 1.70% | 4.33% | -2.20% | |
70 Outperform | $957.09M | 10.71 | 9.61% | 2.59% | 4.49% | 20.44% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $940.07M | 12.79 | 6.53% | 4.73% | 6.27% | 79.25% | |
65 Neutral | $901.08M | 10.70 | 19.62% | 0.04% | 33.22% | 38.44% | |
56 Neutral | $874.22M | 17.00 | 7.21% | 1.79% | 15.37% | ― | |
53 Neutral | $944.40M | 13.68 | 8.53% | 4.59% | -4.08% | -16.80% |
Amerant Bancorp Inc., a Florida-focused bank holding company serving retail, commercial and international customers, has built an established franchise in South Florida, Tampa and Central Florida with a strong deposit base and a vertically integrated offering for Latin American clients. The institution complements its core banking with wealth management and custody services and operates on a new integrated technology platform, targeting sustainable growth and improved efficiency in its chosen markets.
On Feb. 11–12, 2026, Amerant presented an investor update deck outlining its strategy following a multiyear transformation that included a core system conversion and the exit from non-core markets in New York and Texas. The materials highlighted the company’s emphasis on organic growth in Florida, continued investment in business development and credit risk talent, and the leadership transition to interim CEO Carlos Iafigliola, underscoring management’s focus on risk management, digital transformation and achieving top-quartile performance for shareholders.
The most recent analyst rating on (AMTB) stock is a Hold with a $23.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.
On January 22, 2026, Amerant Bancorp reported fourth-quarter 2025 net income of $2.7 million, or $0.07 per diluted share, sharply lower than the prior quarter, as the bank absorbed higher non-interest expenses and ongoing credit normalization tied to strategic actions to improve risk selection and operational efficiency. For full-year 2025, however, Amerant swung to a net profit of $52.4 million, or $1.26 per diluted share, from a $15.8 million loss in 2024, supported by stronger net interest income, improved net interest margin and higher pre-provision net revenue, even as non-performing assets and classified loans rose and the allowance for credit losses decreased. The board declared a $0.09 per share dividend payable February 27, 2026, and approved a new Class A share repurchase program of up to $40 million through December 31, 2026, signaling confidence in the company’s capital position and long-term strategy despite near-term pressure on asset quality and profitability metrics such as efficiency ratio, ROA and ROE.
The most recent analyst rating on (AMTB) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.
On December 31, 2025, Amerant Bank, N.A., a subsidiary of Amerant Bancorp Inc., entered into an asset sale agreement with Peachtree Group to sell up to five loans with an estimated outstanding principal balance of $74 million. The transaction, which included customary representations, warranties, covenants and closing conditions, closed on January 7, 2026, with the bank ultimately selling three of the five loans to Peachtree for approximately $49.7 million after the purchaser chose not to acquire the remaining two loans, thereby reducing Amerant’s loan exposure and adjusting the composition of its loan portfolio.
The most recent analyst rating on (AMTB) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.
On December 30, 2025, Amerant Bancorp released an investor credit update detailing intensified efforts in the fourth quarter of 2025 to reinforce credit discipline and strengthen credit risk management ahead of year-end. During 2025, the bank’s Credit Administration and Credit Review functions, including a third-party firm, reassessed risk ratings across about 85% of its commercial and CRE loan commitments, with roughly $4.5 billion, or 73%, reviewed through financial statement and covenant analysis in the fourth quarter alone. Management increased oversight through weekly leadership meetings focused on special assets, added resources to accelerate portfolio reviews, and expanded coverage to validate risk ratings, while the Special Assets group pushed resolutions of criticized credits through loan sales and heightened collection efforts on previously charged-off loans. As part of criticized portfolio management, the company moved approximately $94 million of loans from held for investment to held for sale, recognizing a non-routine loss of about $16 million but positioning itself to reduce classified loans by $94 million upon expected sale closings in January 2026. The update showed that estimated non-performing loans rose to about $156.7 million in the fourth quarter of 2025, driven primarily by five loans placed on non-accrual status, with subsequent transfers of $19 million in non-accrual loans to held for sale expected to lower NPLs to around $137 million, while charge-offs of $23 million were partly offset by approximately $18 million in recoveries and previously recorded specific reserves. Special mention and classified loans saw active churn through downgrades, paydowns, charge-offs and loan sales, with a significant portion secured by real estate at relatively conservative loan-to-value ratios, underscoring Amerant’s attempt to clean up problem assets and bolster its balance sheet despite near-term credit costs.
The most recent analyst rating on (AMTB) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.